These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 1348796)

  • 1. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma.
    Ross RK; Yuan JM; Yu MC; Wogan GN; Qian GS; Tu JT; Groopman JD; Gao YT; Henderson BE
    Lancet; 1992 Apr; 339(8799):943-6. PubMed ID: 1348796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China.
    Qian GS; Ross RK; Yu MC; Yuan JM; Gao YT; Henderson BE; Wogan GN; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 1994; 3(1):3-10. PubMed ID: 8118382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan.
    Wang LY; Hatch M; Chen CJ; Levin B; You SL; Lu SN; Wu MH; Wu WP; Wang LW; Wang Q; Huang GT; Yang PM; Lee HS; Santella RM
    Int J Cancer; 1996 Sep; 67(5):620-5. PubMed ID: 8782648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan.
    Yu MW; Lien JP; Chiu YH; Santella RM; Liaw YF; Chen CJ
    J Hepatol; 1997 Aug; 27(2):320-30. PubMed ID: 9288607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
    Yu MW; Lien JP; Liaw YF; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan.
    Sun CA; Wu DM; Wang LY; Chen CJ; You SL; Santella RM
    Br J Cancer; 2002 Oct; 87(9):966-70. PubMed ID: 12434285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of individual aflatoxin exposure among people having different risk to primary hepatocellular carcinoma.
    Sun TT; Wu SM; Wu YY; Chu YR
    Princess Takamatsu Symp; 1985; 16():225-35. PubMed ID: 3025163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary aflatoxin levels, hepatitis-B virus infection and hepatocellular carcinoma in Taiwan.
    Hatch MC; Chen CJ; Levin B; Ji BT; Yang GY; Hsu SW; Wang LW; Hsieh LL; Santella RM
    Int J Cancer; 1993 Jul; 54(6):931-4. PubMed ID: 8392983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The association between aflatoxin exposure and primary hepatocellular carcinoma risks: a case-control study in Chongqing].
    Zheng CF; Zeng H; Wang J; Lin H; Feng XB; Chen JA; Qiu ZQ; Luo JH; Xu AW; Wang LQ; Tan Y; Chen S; Jiang P; Shu WQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):539-545. PubMed ID: 28592100
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatocellular carcinoma: from gene to public health.
    Montesano R; Hainaut P; Wild CP
    J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
    Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
    Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
    Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
    Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya.
    Autrup H; Seremet T; Wakhisi J; Wasunna A
    Cancer Res; 1987 Jul; 47(13):3430-3. PubMed ID: 3034416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma antioxidant vitamins, chronic hepatitis B virus infection and urinary aflatoxin B1-DNA adducts in healthy males.
    Yu MW; Chiang YC; Lien JP; Chen CJ
    Carcinogenesis; 1997 Jun; 18(6):1189-94. PubMed ID: 9214602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correspondence re: G-S. Qian, et al., A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol., Biomarkers & Prev., 3:3-10, 1994, and C.C. Harris, Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol., Biomarkers & Prev., 3:1-2, 1994.
    Campbell TC
    Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):519-21. PubMed ID: 8000305
    [No Abstract]   [Full Text] [Related]  

  • 18. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
    Chen CJ; Zhang YJ; Lu SN; Santella RM
    Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflatoxins as a cause of hepatocellular carcinoma.
    Kew MC
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
    Wogan GN; Kensler TW; Groopman JD
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.